First Eagle Investment Management
MRVI icon

First Eagle Investment Management’s Maravai LifeSciences MRVI Stock Holding History

First Eagle Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.9M Buy
3,671,287
+1,146,951
+45% +$4.95M 0.04% 120
2026
Q1 		$7.14M Buy
2,524,336
+725,000
+40% +$2.46M 0.01% 234
2025
Q4 		$5.85M Buy
1,799,336
+1,348,405
+299% +$4.54M 0.01% 240
2025
Q3 		$1.29M Buy
+450,931
New +$1.15M ﹤0.01% 325

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management's MRVI Position: Q2 2026 in Review

First Eagle Investment Management increased its Maravai LifeSciences (MRVI) stake by 45% in Q2 2026, buying an estimated $4.95M and bringing the position to 3,671,287 shares worth $22.9M. The position accounts for 0.04% of the portfolio, ranked #120.

First Eagle Investment Management first reported a position in MRVI in Q3 2025 and has held it in 4 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • First Eagle Investment Management held 3,671,287 shares of Maravai LifeSciences worth $22.9M as of Q2 2026.
  • First Eagle Investment Management bought 1,146,951 Maravai LifeSciences shares in Q2 2026, an estimated $4.95M.
  • Maravai LifeSciences made up 0.04% of First Eagle Investment Management's portfolio in Q2 2026, its #120 holding.
  • First Eagle Investment Management first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.